查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370548

上市后药物警戒与医疗资讯市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Post-marketing Pharmacovigilance and Medical Information Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年全球上市后药物警戒与医疗资讯市场规模达51亿美元。展望未来，IMARC集团预计到2028年市场规模将达到94亿美元，2023-2028年复合年增长率（CAGR）为10.9% 。

上市后药物警戒和医疗资讯是在药品和医疗器材上市后监测其安全性和有效性的做法。它包括收集、监测和预防新药物、设备和疗法的不良反应。它透过澄清与益处有关的风险并反驳错误的指示，帮助保护患者免受不必要的伤害。除此之外，它还可以帮助研究人员确定整个药物配方週期所需的行动。因此，上市后药物警戒和医疗资讯在医疗保健行业中发挥重要作用，可评估患者和医疗专业人员之间传递的讯息的准确性。研究组织也使用它来规范药物安全指南。

上市后药物警戒与医疗资讯市场趋势：

全球老年人口的不断增长以及糖尿病、高血压、失智症、心血管疾病和骨质疏鬆症等各种慢性疾病的发生率不断上升，是增加药品消费的关键因素之一。此外，生活方式、呼吸道和心血管感染以及神经和肿瘤疾病的日益频繁导致全球药品销售的增加。这反过来又创造了积极的市场前景。与此一致的是，药物不良反应 (ADR) 的发生率不断上升，加上先进的 ADR 报告工具的采用，正在支持市场的成长。除此之外，医院、诊所、实验室和医学研究中心的扩张正在刺激全球对药物和医疗设备的需求。此外，各国政府正在实施多项措施来改善医疗基础设施和药物警戒服务并维护医疗资料库，这正在加强市场成长。此外，领先的市场参与者正专注于外包药物警戒业务（PVO）并引入基于云端的医疗资讯系统，以实现最佳准确性、成本效率、风险缓解、领域、改进的时间表和组织敏捷性，预计这将推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球上市后药物警戒和医疗资讯市场的表现如何，未来几年将如何表现？
  • COVID-19 对全球上市后药物警戒与医疗资讯市场有何影响？
  • 主要区域市场有哪些？
  • 依类型划分市场是怎么样的？
  • 基于产品的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球上市后药物警戒和医疗资讯市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球上市后药物警戒与医疗资讯市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按类型分類的市场细分

  • 自发性报告
    • 市场走向
    • 市场预测
  • 强化 ADR 报告
    • 市场走向
    • 市场预测
  • 针对性的自发性报告
    • 市场走向
    • 市场预测
  • 群组事件监控
    • 市场走向
    • 市场预测
  • 电子病历采矿
    • 市场走向
    • 市场预测

第 7 章：按产品分類的市场区隔

  • 图书
    • 市场走向
    • 市场预测
  • 网路媒体
    • 市场走向
    • 市场预测
  • 期刊
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accenture Plc.
    • ArisGlobal
    • Cognizant Technology Solutions Corporation
    • Ergomed Plc
    • F. Hoffmann-La Roche Ltd.
    • Icon Plc
    • Parexel International Corporation
    • Pharmaceutical Product Development, Inc.
    • Wipro Ltd.
Product Code: SR112023A6454

Abstract

Market Overview:

The global post-marketing pharmacovigilance and medical information market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.9% during 2023-2028.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product and end user.

Breakup by Type:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Breakup by Product:

Books

Online Media

Journals

Breakup by End User:

Hospitals

Research Organization

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report:

  • How has the global post-marketing pharmacovigilance and medical information market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global post-marketing pharmacovigilance and medical information market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Spontaneous Reporting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intensified ADR Reporting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Targeted Spontaneous Reporting
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cohort Event Monitoring
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 EHR Mining
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Books
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Online Media
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Journals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accenture Plc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ArisGlobal
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cognizant Technology Solutions Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ergomed Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 F. Hoffmann-La Roche Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Icon Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Wipro Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
  • Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
  • Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
  • Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
  • Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players